This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Kinoxis Therapeutics Pty Ltd. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- The University of Sydney, AU (2022)
- Cammeray, AU (2021 - 2024)
Company Filing History:
Years Active: 2021-2025
Title: Michael Thomas Bowen: Innovator in Therapeutic Compounds
Introduction
Michael Thomas Bowen is a notable inventor based in Cammeray, Australia. He has made significant contributions to the field of therapeutic compounds, particularly in the treatment of social disorders and substance use disorders. With a total of 4 patents to his name, Bowen's work is paving the way for advancements in neurological and psychiatric treatments.
Latest Patents
Bowen's latest patents focus on therapeutic compounds and compositions designed to treat neurological and psychiatric disorders characterized by disruptions in social behavior. These patents disclose compounds of Formula (I), along with their salts and prodrugs, which are aimed at treating or preventing these disorders. The innovative methods outlined in his patents provide new avenues for addressing complex social and substance use issues.
Career Highlights
Michael Thomas Bowen is currently associated with Kinoxis Therapeutics Pty Ltd, where he continues to develop groundbreaking therapeutic solutions. His work is instrumental in advancing the understanding and treatment of disorders that affect social behavior and substance use.
Collaborations
Bowen collaborates with esteemed colleagues, including Iain Stewart McGregor and Michael Kassiou, to further enhance the impact of his research and innovations.
Conclusion
Michael Thomas Bowen's contributions to the field of therapeutic compounds are significant and impactful. His innovative approaches to treating social and substance use disorders highlight the importance of research in improving mental health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile